LA JOLLA, CA\u2014The Salk Institute is pleased to announce that Alan D. Gold and David F. Hale have been elected to its Board of Trustees.\n <\/p>\n
\n“Alan and David each bring outstanding records of entrepreneurial success and business expertise to Salk,” said Irwin M. Jacobs, Chairman of the Salk Institute Board of Trustees. “We are greatly pleased to have them join our Board of Trustees.”\n <\/p>\n
\nAlan D. Gold<\/strong> is chairman and chief executive officer of Biomed Realty, a publicly traded REIT specializing in acquiring and managing laboratory properties for lease to the life science industry. Mr. Gold also served as president of BioMed’s privately held predecessor, Bernardo Property Advisors, Inc. He was a co-founder and served as president and as a director of Alexandria Real Estate Equities, Inc. He was managing partner of GoldStone Real Estate Finance and Investments, a partnership engaged in the real estate and mortgage business. He also served as assistant vice president of Commercial Real Estate for Northland Financial Company, a full service commercial property mortgage banker, and as Real Estate Investment Officer – Commercial Real Estate for John Burnham Company, a regional full service real estate company. He currently serves on the Campanile Foundation Board supporting San Diego State University.\n <\/p>\n \nDavid F. Hale<\/strong> is chairman and chief executive officer of Hale BioPharma Ventures, LLC, a private company focused on the formation and development of biotechnology, specialty pharma, diagnostic, and medical device companies. He also serves as executive chairman of Biocept, Inc., a cancer diagnostic company working on the detection and analysis of circulating tumor cells. Previously, he was president and chief executive officer of CancerVax Corporation from October 2000 through its merger in May 2006 with Micromet, Inc. where he served as chairman until its acquisition by Amgen Inc. in 2012. Additionally, Mr. Hale is chairman of Santarus, Inc., and a founding director and chairman of Conatus Pharmaceuticals, Inc. He is a co-founder and chairman of numerous other companies. Mr. Hale currently serves on the board of directors of BIOCOM, which he co- founded, and the San Diego Economic Development Corporation. He is a former member of the board of the Biotechnology Industry Organization (BIO) and the Biotechnology Institute. He is a co-founder and a director of CONNECT, acts as chairman of the board of trustees of Rady Children’s Hospital, and is a member of Rady School of Management Dean’s Advisory Council.\n <\/p>\n \nLos logros del cuerpo docente han sido reconocidos con numerosos galardones, entre los que se incluyen premios Nobel y la pertenencia a la Academia Nacional de Ciencias. Fundado en 1960 por el Dr. Jonas Salk, pionero en la vacuna contra la poliomielitis, el Instituto es una organizaci\u00f3n independiente sin fines de lucro y un hito arquitect\u00f3nico.<\/p>","protected":false},"featured_media":0,"template":"","faculty":[],"disease-research":[144],"class_list":["post-2462","disclosure","type-disclosure","status-publish","hentry","disease-research-leadership"],"acf":[],"yoast_head":"\n
\nAcerca del Instituto Salk de Estudios Biol\u00f3gicos:<\/strong>
\nEl Instituto Salk de Estudios Biol\u00f3gicos es una de las instituciones de investigaci\u00f3n b\u00e1sica m\u00e1s destacadas del mundo, donde un cuerpo docente de prestigio internacional investiga cuestiones fundamentales de las ciencias de la vida en un entorno \u00fanico, colaborativo y creativo. Centrados tanto en el descubrimiento como en la formaci\u00f3n de las futuras generaciones de investigadores, los cient\u00edficos del Salk realizan contribuciones revolucionarias a nuestra comprensi\u00f3n del c\u00e1ncer, el envejecimiento, el Alzheimer, la diabetes y las enfermedades infecciosas mediante el estudio de la neurociencia, la gen\u00e9tica, la biolog\u00eda celular y vegetal, y otras disciplinas relacionadas.\n <\/p>\n